Home Science Trial drug can significantly block early stages of COVID-19 in engineered human...TechScienceTrial drug can significantly block early stages of COVID-19 in engineered human tissuesApril 2, 202096FacebookTwitterPinterestWhatsApp An international team has found a trial drug that effectively blocks the cellular door SARS-CoV-2 uses to infect its hosts.Source: ScienceDaily.com